Ofatumumab For Rituximab-resistant Nephrotic Syndrome
STN 125011 Tositumomab Therapeutic Regimen (TTR) [tositumomab plus I-131 tositumomab] Oncologic Drugs Advisory Committee December 17, 2002.
![STN 125011 Tositumomab Therapeutic Regimen (TTR) [tositumomab plus I-131 tositumomab] Oncologic Drugs Advisory Committee December 17, 2002.](https://static.fdocuments.us/doc/330x215/56649dc45503460f94ab6f7b/stn-125011-tositumomab-therapeutic-regimen-ttr-tositumomab-plus-i-131-tositumomab.jpg)
